A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations: Correspondence

Histopathology

Volumn 55, Issue 4, 2009, Pages 482-487

  Celestino, Ricardo ^a,b   Magalhães, João ^a,b,c   Castro, Patricia ^a   Triller, Marie ^d   Vinagre, João ^a,b   Soares, Paula ^a,b   Sobrinho Simões, Manuel ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

^d Cabinet de Pathologie Tolbiac   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR PAX8;

FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR CARCINOMA; GENE MUTATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; ONCOGENE N RAS; PAPILLARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; TERATOMA; THYROID CARCINOMA;

ADULT; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENES, RAS; HUMANS; MUTATION; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS B-RAF; TERATOMA; THYROID NEOPLASMS;

EID: 70349906782     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03401.x     Document Type: Letter

References (15)

1. Tavassoli F, Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon : IARC Press, 2003.
2. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int. J. Gynecol. Pathol. 1993 12 333 343.
3. Elisei R, Romei C, Castagna MG et al. RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration. Thyroid 2005 15 1355 1361.
4. DeLellis RA, Lloyd RV, Heitz PU, Eng C. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon : IARC Press, 2004.
5. Makani S, Kim W, Gaba AR. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol. Oncol. 2004 94 835 839.
6. Yassa L, Sadow P, Marqusee E. Malignant struma ovarii. Nat. Clin. Pract. Endocrinol. Metab. 2008 4 469 472.
7. Castro P, Rebocho AP, Soares RJ et al. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 2006 91 213 220.
8. Boutross-Tadross O, Saleh R, Asa SL. Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr. Pathol. 2007 18 182 186.
9. Flavin R, Smyth P, Crotty P et al. BRAF T1799A mutation occurring in a case of malignant struma ovarii. Int. J. Surg. Pathol. 2007 15 116 120.
10. Schmidt J, Derr V, Heinrich MC et al. BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am. J. Surg. Pathol. 2007 31 1337 1343.
11. Trovisco V, Vieira DCI, Soares P et al. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J. Pathol. 2004 202 247 251.
12. Sobrinho-Simoes M, Maximo V, Rocha AS et al. Intragenic mutations in thyroid cancer. Endocrinol. Metab. Clin. North Am. 2008 37 333 362, viii
13. Soares P, Trovisco V, Rocha AS et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 2003 22 4578 4580.
14. Rhoden KJ, Unger K, Salvatore G et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J. Clin. Endocrinol. Metab. 2006 91 2414 2423.
15. Nikiforova MN, Lynch RA, Biddinger PW et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J. Clin. Endocrinol. Metab. 2003 88 2318 2326.